- Product Details
Keywords
- Noopept
- (S)-ethyl 2-(1-(2-phenylacetyl)pyrrolidine-2-carboxaMido)acetate
- CAS157115-85-0
Quick Details
- ProName: ethyl 2-[[(2S)-1-(2-phenylacetyl)pyrro...
- CasNo: 157115-85-0
- Molecular Formula: C17H22N2O4
- Appearance: powder
- Application: Pharmaceutical Intermediates
- DeliveryTime: 3-5 woking days
- PackAge: Conventional packing or as your requir...
- Port: ShenZhen/ ShangHai
- ProductionCapacity: 500 Metric Ton/Month
- Purity: 99.9%
- Storage: ConditionsStore in a cool and dry plac...
- Transportation: Pharmaceutical Intermediates
- LimitNum: 10 Gram
Superiority
Noopept (GVS-111) is a medication promoted and prescribed in Russia and neighbouring countries as a nootropic.IC50 Value:Target: in vitro: Nooglutil exhibits pharmacologically significant competition with a selective agonist of AMPA receptors ([G-3H]Ro 48-8587) for the receptor binding sites (with IC50 = 6.4 +/- 0.2 microM), while the competition of noopept for these receptor binding sites was lower by an order of magnitude (IC50 = 80 +/- 5.6 microM) [1]. GVS-111 significantly increased
Details
CAS No. | 157115-85-0 |
Formula | C17H22N2O4 |
Molecular Weight | 318.373 |
EINECS | 1592732-453-0 |
CID | 180496 |
Density | 1.202 |
Boiling Point | 547.3°Cat760mmHg |
Melting Point | 94.0 to 98.0 °C |
Flash Point | 284.8°C |
Synonyms
(S)-ethyl 2-(1-(2-phenylacetyl)pyrrolidine-2-carboxaMido)acetate; 1-(2-Phenylacetyl)-L-prolylglycine ethy ester; Ethyl 1-(phenylacetyl)-L-prolylglycinate; ethyl 2-[[(2S)-1-(2-phenylacetyl)pyrrolidine-2-carbonyl]amino]acetate; Ethyl N-[1-(Phenylacetyl)-L-prolyl]glycinate;